Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novartis Ag ADR (NY: NVS ) 119.13 +0.57 (+0.48%) Streaming Delayed Price Updated: 3:20 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 474,503 Open 118.69 Bid (Size) 119.13 (3) Ask (Size) 119.14 (1) Prev. Close 118.56 Today's Range 118.68 - 119.29 52wk Range 92.19 - 118.59 Shares Outstanding N/A Dividend Yield 2.91% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats Today 10:21 EDT The company is gearing up to rival giants Gilead and Novartis with a potentially decentralized CAR-T process. Via Investor's Business Daily Exposures Product Safety Siemens Healthineers To Buy Novartis Diagnostics To Bolster Cancer Scan Business In $220M Deal Today 8:54 EDT Siemens Healthineers to acquire Novartis' diagnostics division for over €200M, securing a vital supply of radioactive chemicals used in PET scans to enhance its European presence and cancer imaging... Via Benzinga Performance YTD +17.95% +17.95% 1 Month +7.99% +7.99% 3 Month +19.51% +19.51% 6 Month +15.38% +15.38% 1 Year +16.41% +16.41% More News Read More Uncovering Dividend Opportunities with NYSE:NVS. August 23, 2024 Via Chartmill 2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200 August 18, 2024 Via The Motley Fool Judge Rules Against Novartis' Effort To Halt Generic Launch Of Its Top-Selling Heart Disease Drug August 13, 2024 Via Benzinga The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors August 12, 2024 Via Newsfile Exposures Product Safety Good technical signals and a possible breakout for NOVARTIS AG-SPONSORED ADR. August 07, 2024 Via Chartmill Why NYSE:NVS is a Top Pick for Dividend Investors. August 02, 2024 Via Chartmill BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Reports on ‘Synergistic Effect’ of Lead Compound Plus GLP-1 in AD Treatment Model August 08, 2024 Via Investor Brand Network FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease August 08, 2024 Via Benzinga Exposures Product Safety Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs August 06, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Alzheimer’s Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities August 06, 2024 Via FinancialNewsMedia Novartis Reports Near 40% Margin In Q2; Shares Slide July 18, 2024 Via Investor's Business Daily Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities August 06, 2024 From FN Media Group LLC Via GlobeNewswire Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update July 30, 2024 From Arvinas Inc. Via GlobeNewswire AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife July 23, 2024 Via Benzinga Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review July 19, 2024 Via Investor's Business Daily Pharma Leader Beats on Earnings, But Shares Fall July 19, 2024 Via MarketBeat Topics Intellectual Property Exposures Intellectual Property Novartis Ag (NVS) Q2 2024 Earnings Call Transcript July 18, 2024 Via The Motley Fool Topics Earnings Exposures Financial Why Novartis Stock Is Down Today Despite Topping Q2 Estimates July 18, 2024 Via The Motley Fool VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday? July 18, 2024 Via Benzinga Topics Stocks Exposures US Equities Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs July 18, 2024 Via Benzinga Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens July 18, 2024 Via Benzinga Topics Economy Exposures Interest Rates Alnylam Stock Is a Blockbuster Biopharma In the Making July 18, 2024 Via InvestorPlace NVS Stock Earnings: Novartis Beats EPS, Beats Revenue for Q2 2024 July 18, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
